premenopausal women with ipsilateral axillary node-positive breast carcinoma and known estrogen receptor ( er ) status were randomized to receive 1 year of postoperative treatment with 12 28-day cycles of cyclophosphamide , methotrexate , 5-fluorouracil ( cmf ) , cmf plus prednisone ( cmfp ) , or cmfp plus tamoxifen ( cmfpt ) .
C0032952
prednisone
C0055985
cmfp